Abiopharma

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.

Avantor® Expands Centralized Service Center Model with Opening of Boston-Area Facility

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

A New Press Release from Elicio Therapeutics

Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations

BioVie Inc. - Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

Quantum-Si to Highlight Significant Proteus™Platform Development Progress and Provide Insights into theCompany’s Industry Leading Technology Pipeline at Investor & Analyst Day

Esperion to Participate in Piper Sandler 37th Annual Healthcare Conference

Teva Pharmaceutical Industries Ltd. - Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’sBiggest Challenges